Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Generic medicines

Voluntary licensing via the Medicines Patent Pool is saving hundreds of thousands of lives

News
9 February 2022
Pharmaceutical industry

Deborah Waterhouse: ‘The HIV stigma remains, and this is a battle we’ve got to fight’

Editor's pick
The Guardian
7 February 2022
Pharmaceutical industry

GSK to get $1.25 bln to settle HIV drug patent row with Gilead

Editor's pick
Reuters
2 February 2022
Pharmaceutical industry

CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill

Editor's pick
FierceBiotech
27 January 2022
PrEP policies & guidelines

United States v. Gilead: Two Year Anniversary Letter

Editor's pick
PrEP4All
21 January 2022
HIV treatment

US: Gilead says counterfeiting network sold $250 mln worth of its HIV drugs

Editor's pick
Reuters
19 January 2022
Injectable & long-acting PrEP

Fair Pricing Coalition Welcomes Approval Of Two-Month HIV Prevention Shot; Denounces ViiV Healthcare’s Exorbitant, Unsustainable Pricing

Editor's pick
Fair Pricing Coalition
26 December 2021
Injectable & long-acting HIV treatment

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir

Editor's pick
FiercePharma
26 December 2021
Injectable & long-acting PrEP

GlaxoSmithKline's HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it?

Editor's pick
FiercePharma
26 December 2021
New & experimental HIV treatments

Trials of long-acting islatravir for HIV treatment and prevention placed on hold

News
21 December 2021
Injectable & long-acting HIV treatment

Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection

Editor's pick
Merck press release
14 December 2021
Pharmaceutical industry

'Pharma Bro' firm reaches $40M settlement in gouging case

Editor's pick
Associated Press
9 December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021
Injectable & long-acting HIV treatment

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

Editor's pick
Medicines Patent Pool
9 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021
The search for a cure

How Long To An HIV Cure? As GSK Therapy Heads For Human Trials, Where We Are In Fight Against Virus

Editor's pick
News18
1 December 2021
Coronavirus

The New COVID Drugs Are a Bigger Deal Than People Realise

Editor's pick
The Atlantic
29 November 2021
Coronavirus

New licenses could spark manufacture of COVID-19 pills in Africa

Editor's pick
Spotlight
29 November 2021
New & experimental HIV treatments

Gilead and Merck Announce Temporary Pause in Enrolment for Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Islatravir and Investigational Lenacapavir ​​​​​​​

Editor's pick
Gilead Sciences
26 November 2021
Health services & systems

President of Rwanda Urges African Parliaments to Back new African Medicines Agency, the continent's new regulatory authority

Editor's pick
AllAfrica
25 November 2021
Self-testing & home testing

Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd

Editor's pick
GlobeNewswire
24 November 2021
New & experimental HIV treatments

Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo

Editor's pick
FierceBiotech
22 November 2021
Activism & civil society

A Financial Disaster Hits US HIV Agencies in January. Why Won’t Anyone Stop It?

Editor's pick
My Fabulous Disease
16 November 2021